Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Rain Therapeutics
Biotech
Biotechs shed dead wood from pipelines amid cash crunch
The latest batch of quarterly updates saw Atreca, aTyr Pharma, Histogen, Lisata, Poseida and Rain trim their pipelines.
Nick Paul Taylor
Nov 11, 2022 9:25am
Rain tees up $100M IPO to push ex-Daiichi cancer drug into phase
Apr 5, 2021 9:45am
Rain bags $63M, ex-Daiichi cancer drug to mount pivotal push
Sep 4, 2020 8:05am
